Evidence map›Paper›PMID 40702968›Full record

ArticleHealth promotion international2025

Navigating US illicit drug market volatility: harm reduction strategies employed by people who inject drugs.

Abigail K Winiker, Laura N Sisson, Kristin E Schneider, Saba Rouhani, Emily M Martin, Danielle Friedman Nestadt, Bradley E Silberzahn, Leanne Zhang, Katherine Footer, Susan G Sherman

Abstract read
In one paragraph

Article in Health promotion international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abigail K WinikerDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.ORCID 0000-0002-0146-1920
Laura N SissonDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Kristin E SchneiderDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Saba RouhaniDepartment of Epidemiology, New York University School of Global Public Health, 708 Broadway, New York, New York 10003, USA.
Emily M MartinDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Danielle Friedman NestadtDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Bradley E SilberzahnDepartment of Sociology, University of Texas at Austin, 110 Inner Campus DriveAustin, Texas 78712, USA.
Leanne ZhangDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Katherine FooterDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.
Susan G ShermanDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, Maryland 21205, USA.

Funding

NIDA NIH HHS 1R01DA053184NIDA NIH HHS T32DA007292-31A1
6 · The paper itself

Abstract

The US illicit drug market is increasingly unreliable, with new and often harmful adulterants contributing to overdose risk among people who use drugs. In this context, it is crucial to examine whether people who inject drugs (PWID) are aware of these changes and if so, how they are adapting to inform harm reduction interventions and programs. In-depth interviews were conducted with 23 PWID between July 2022 and January 2023. Interviews explored participants' substance use behaviors and perspectives on harm reduction interventions. A combined deductive and inductive thematic analysis was conducted to identify emergent themes. This analysis focuses upon participants' discussions around drug market activity/changes, drug-related harms, drug use risk perceptions, and harm reduction strategies. Participants demonstrated awareness of the increasing volatility and risk associated with illicit substance use. They reported engaging a range of strategies to reduce the risk of these harms, motivated by individual-level cognitions and behaviors, as well as external-level interpersonal relationship dynamics. These findings highlight that perceived risk translates to behavior change amid a changing market, suggesting the need for universal drug testing access, responsive health education/harm reduction programming, peer-based interventions, and structural changes to reduce barriers to harm reduction behavior change.

Indexed as

Harm ReductionIllicit DrugsSubstance Abuse, IntravenousAdultFemaleHumansInterviews as TopicMaleMiddle AgedQualitative ResearchRisk-TakingUnited StatesIllicit Drugsdeterminants of healthevidence based policyharm minimizationhealth behaviourinterventionsubstance use

Identifiers

PMID40702968
PMCPMC12287601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.